Literature DB >> 22037389

Link between decisions regarding resuscitation and preferences for quality over length of life with heart failure.

Sandesh Dev1, Robert M Clare, G Michael Felker, Mona Fiuzat, Lynne Warner Stevenson, Christopher M O'Connor.   

Abstract

AIMS: Survival preferences, ascertained from time-trade-off utilities, have not been studied in heart failure patients who designate a 'do not resuscitate' (DNR) status. Therefore, the aim of this study was to determine the association of heart failure patients' resuscitation preferences with survival preferences and mortality in the ESCAPE trial. METHODS AND
RESULTS: We analysed the association of resuscitation orders at 1 month with time-trade-off utilities and 6-month mortality. There were 26 and 349 patients with a DNR order and Full Code order, respectively. DNR patients were older, had more coronary artery disease, hypertension, renal impairment, and poorer exercise capacity than Full Code patients. DNR patients also experienced longer hospitalization and higher 6-month mortality. In multivariate analysis, DNR preference was associated with 10-fold higher odds of willingness to trade survival time (lower time-trade-off utility) in favour of improved quality of life [odds ratio 10.33, 95% confidence interval (CI) 1.65-64.80]. DNR preference was the best predictor of mortality (χ(2) 26.12, P < 0.0001, hazard ratio 6.88, 95% CI 3.28-14.41), despite adjustment for known predictors including brain natriuretic peptide.
CONCLUSIONS: Heart failure patients' requests to forego resuscitation may signify more than simply 'what-if' directives for emergency care. DNR decisions may reflect preferences for intervention to enhance quality rather than prolong survival, which is particularly important as these patients have high early mortality.

Entities:  

Mesh:

Year:  2011        PMID: 22037389      PMCID: PMC3276239          DOI: 10.1093/eurjhf/hfr142

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  20 in total

Review 1.  Inotropic therapy for heart failure: an evidence-based approach.

Authors:  G M Felker; C M O'Connor
Journal:  Am Heart J       Date:  2001-09       Impact factor: 4.749

2.  Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): design and rationale.

Authors:  M R Shah; C M O'Connor; G Sopko; V Hasselblad; R M Califf; L W Stevenson
Journal:  Am Heart J       Date:  2001-04       Impact factor: 4.749

3.  The relationship between health perception and utility in heart failure patients in a clinical trial: results from an OVERTURE substudy.

Authors:  Edward P Havranek; Teresa A Simon; Gilbert L'Italien; Allison Smitten; A Brett Hauber; Roland Chen; Pablo Lapuerta
Journal:  J Card Fail       Date:  2004-08       Impact factor: 5.712

4.  Racial and ethnic differences in preferences for end-of-life treatment.

Authors:  Amber E Barnato; Denise L Anthony; Jonathan Skinner; Patricia M Gallagher; Elliott S Fisher
Journal:  J Gen Intern Med       Date:  2009-04-23       Impact factor: 5.128

5.  End-of-life care preferences of patients enrolled in cardiovascular rehabilitation programs.

Authors:  J E Heffner; C Barbieri
Journal:  Chest       Date:  2000-05       Impact factor: 9.410

6.  Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score.

Authors:  Christopher M O'Connor; Vic Hasselblad; Rajendra H Mehta; Gudaye Tasissa; Robert M Califf; Mona Fiuzat; Joseph G Rogers; Carl V Leier; Lynne W Stevenson
Journal:  J Am Coll Cardiol       Date:  2010-03-02       Impact factor: 24.094

7.  Understanding the treatment preferences of seriously ill patients.

Authors:  Terri R Fried; Elizabeth H Bradley; Virginia R Towle; Heather Allore
Journal:  N Engl J Med       Date:  2002-04-04       Impact factor: 91.245

8.  Health values of the seriously ill. SUPPORT investigators.

Authors:  J Tsevat; E F Cook; M L Green; D B Matchar; N V Dawson; S K Broste; A W Wu; R S Phillips; R K Oye; L Goldman
Journal:  Ann Intern Med       Date:  1995-04-01       Impact factor: 25.391

9.  Changing preferences for survival after hospitalization with advanced heart failure.

Authors:  Lynne W Stevenson; Anne S Hellkamp; Carl V Leier; George Sopko; Todd Koelling; J Wayne Warnica; William T Abraham; Edward K Kasper; Joseph G Rogers; Robert M Califf; Elizabeth E Schramm; Christopher M O'Connor
Journal:  J Am Coll Cardiol       Date:  2008-11-18       Impact factor: 24.094

Review 10.  Partial do-not-resuscitate orders: A hazard to patient safety and clinical outcomes?

Authors:  Alan Sanders; Melissa Schepp; Marianne Baird
Journal:  Crit Care Med       Date:  2011-01       Impact factor: 7.598

View more
  6 in total

Review 1.  Decision Making Among Persons Living With Heart Failure.

Authors:  Jiayun Xu; Martha Abshire; Hae-Ra Han
Journal:  J Cardiovasc Nurs       Date:  2016 Sep-Oct       Impact factor: 2.083

2.  Resuscitation preferences in community patients with heart failure.

Authors:  Shannon M Dunlay; Keith M Swetz; Margaret M Redfield; Paul S Mueller; Véronique L Roger
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-05-13

3.  Decision making in advanced heart failure: a scientific statement from the American Heart Association.

Authors:  Larry A Allen; Lynne W Stevenson; Kathleen L Grady; Nathan E Goldstein; Daniel D Matlock; Robert M Arnold; Nancy R Cook; G Michael Felker; Gary S Francis; Paul J Hauptman; Edward P Havranek; Harlan M Krumholz; Donna Mancini; Barbara Riegel; John A Spertus
Journal:  Circulation       Date:  2012-03-05       Impact factor: 29.690

4.  Handling incomplete correlated continuous and binary outcomes in meta-analysis of individual participant data.

Authors:  Manuel Gomes; Laura Hatfield; Sharon-Lise Normand
Journal:  Stat Med       Date:  2016-04-18       Impact factor: 2.373

5.  Importance and added value of functional impairment to predict mortality: a cohort study in Swedish medical inpatients.

Authors:  Gustav Torisson; Lars Stavenow; Lennart Minthon; Elisabet Londos
Journal:  BMJ Open       Date:  2017-05-30       Impact factor: 2.692

Review 6.  Endpoints in Heart Failure Drug Development.

Authors:  Aliza Hussain; Arunima Misra; Biykem Bozkurt
Journal:  Card Fail Rev       Date:  2022-01-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.